story of the week
Adjuvant Atezolizumab After Adjuvant Chemotherapy in Resected Stage IB–IIIA NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
Lancet 2021 Sep 17;[EPub Ahead of Print], E Felip, N Altorki, C Zhou, T Csőszi, I Vynnychenko, O Goloborodko, A Luft, A Akopov, A Martinez-Marti, H Kenmotsu, YM Chen, A Chella, S Sugawara, D Voong, F Wu, J Yi, Y Deng, M McCleland, E Bennett, B Gitlitz, H WakeleeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.